Welcome to our dedicated page for uniQure N.V. SEC filings (Ticker: QURE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on uniQure N.V.'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into uniQure N.V.'s regulatory disclosures and financial reporting.
UniQure N.V. submitted a Form 144 notice reporting proposed dispositions of Ordinary Shares tied to equity compensation. The filing lists 7,970 Ordinary Shares from restricted stock unit vesting on 06/11/2026 and 10,000 Ordinary Shares from a stock option exercise and sale pursuant to a 10b5-1 plan on 06/15/2026. The filing indicates the exercise-sale on 06/15/2026 was for cash and that the restricted stock units vesting on 06/11/2026 were issued for services rendered.
UniQure N.V. reports a proposed Rule 144 sale of 7,970 ordinary shares tied to restricted stock unit vesting on 06/11/2026. The filing lists a broker, Citigroup Global Markets, Inc., and shows 7,552 ordinary shares sold on 06/10/2026 for $196,725.35. The filing also includes a disclosed share figure of 63,067,485 shares outstanding as of 06/11/2026.
Jack Kaye filed a Form 144 reporting a proposed sale of 7,970 ordinary shares attributable to restricted stock units vesting on 06/11/2026. The filing lists Citigroup Global Markets, Inc. as the broker. It also records a prior sale of 2,645 shares on 06/03/2026.
UniQure N.V. reported a sale of 2,645 ordinary shares on 06/10/2026 via a stock options exercise and sale pursuant to a 10b5-1 plan. The filing also lists vested share items of 3,127 shares (vested 02/27/2020) and 1,780 shares (vested 02/25/2021), described as compensation-related. The excerpt identifies the broker as Citigroup Global Markets, Inc. and indicates transactions on NASDAQ.
uniQure N.V. director Kaye Jack reported an option exercise paired with a share sale. On June 3, 2026, Jack exercised stock options to acquire 2,645 Ordinary Shares at $16.04 per share and sold 2,645 Ordinary Shares in open-market transactions at an average price of $30.01 per share. These transactions were made under a pre-arranged Rule 10b5-1 trading plan adopted on June 16, 2025. After the trades, Jack directly owned 20,439 Ordinary Shares, and the exercised stock option for 2,645 shares, which had vested in full on February 24, 2023, was fully used.